{"schema_version":"secwatch.filing_event.v1","accession":"0001388658-26-000038","form_type":"8-K","ticker":"IRTC","cik":"0001388658","company_name":"iRhythm Holdings, Inc.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.221740+00:00","generated_at":"2026-05-15T00:36:54.655023+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"iRhythm Q1 revenue $199.4M (+25.7%), net loss narrows; raises FY2026 outlook","bullets":["Revenue of $199.4M, up 25.7% YoY; net loss $13.9M ($0.43/sh) vs $30.7M ($0.97/sh) in Q1 2025.","Adjusted EBITDA turned positive at $14.1M (7.1% margin) vs -$2.6M (-1.7%) a year ago; gross margin 70.9% up 210bps.","Raised FY2026 revenue guidance to $875M-$885M and adjusted EBITDA margin to 12%-13%.","Unrestricted cash $549.6M; presented data at ACC/HRS and launched new digital education platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001388658-26-000038","json":"https://secwatch.observer/filing/0001388658-26-000038.json","markdown":"https://secwatch.observer/filing/0001388658-26-000038.md","text":"https://secwatch.observer/filing/0001388658-26-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388658/000138865826000038/0001388658-26-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388658/000138865826000038/irtc-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:36:54.655023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"545eacfb3d9e1a455669d02e1ce01c4e2e91fb84","claim":"iRhythm Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $199.4 million, net income $13.9 million, EPS $0.43 per diluted share. Guidance raised.","evidence_excerpt":"that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights • Revenue of $199.4 million, a 25.7% increase compared to first quarter 2025 • Gross margin of 70.9%, a 210-basis point increase compared to first quarter 2025 • Net loss of $13.9 million, a $16.8 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865826000038/0001388658-26-000038-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$199.4 million"},{"label":"Net income","value":"$13.9 million"},{"label":"EPS","value":"$0.43 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}